Cite
HARVARD Citation
Bell, G. et al. (n.d.). A randomized, double-blind, phase 2 study evaluating the safety and efficacy of AMG 416 for the treatment of secondary hyperparathyroidism in hemodialysis patients. Current medical research and opinion. pp. 943-952. [Online].